You are here
- Home
- Drug Products
- All Drug Products
Open-Labelled, Single Arm, Phase IV Clinical Study to Evaluate the Impact of Rosuvastatin on Lipid Levels in Patients With Metabolic Syndrome (EFFORT)
- Disease
- hypercholesterolaemia, diabetes type 2, dyslipidaemia
- Drug Name
- Crestor
- Generic Name
- rosuvastatin
- Sponsor
- AstraZeneca
- Drug Status
- Approved Medicine
- Phase
- IV
- Start Date
- Dec 12, 2008
- Study Name
- D3560L00079
- Study Id
- D3560L00079
- ClinicalTrials.gov ID
- NCT00815659
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report
-
Mar 7, 2011
